BAC
Bank of America Corporation
BAC offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
HMN
Horace Mann Educators Corporation
HMN has a slight edge over BAC overall, supported by stronger valuation and lower modeled downside.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
HMN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| N/A | |
| N/A |
HMN's profitability is currently healthy, and its revenue is stable. Free cash flow and net leverage aren't meaningful measures for financial services companies like HMN.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC has the edge over HMN in the historical PE scenario, which offers more potential upside but is not a forecast.
HMN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 11x | $45.56 | -14% |
| Forward | 11x | $52.78 | — |
| Current | 12x | $52.78 | — |
| Fair | 13x | $57.21 | +8.4% |
| Expensive | 21x | $88.69 | +68% |
Historical ranges are pointers, not guarantees.
HMN's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 11x next year's earnings, in its cheap range.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over HMN on the outlook, with more favorable revenue expectations.
HMN Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Strongly improving | |
| Limited | |
| High |
Analysts expect HMN's earnings to grow and its profitability to improve, with its revenue holding steady.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC's earnings per share have climbed steadily: $4.19 over the past year, up 14% from the year before, and higher year over year for eight quarters in a row.
HMN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $5.02 | +17% |
| Q3 2026 | $4.29 | +8.6% |
| Q2 2026 | $4.28 | +27% |
| Q1 2026 | $3.98 | +44% |
| Q4 2025 | $3.90 | +57% |
| Q3 2025 | $3.95 | +57% |
| Q2 2025 | $3.38 | +72% |
| Q1 2025 | $2.76 | +76% |
| Q4 2024 | $2.48 | +128% |
HMN has the edge over BAC on earnings, with stronger typical year-over-year growth.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over HMN on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over HMN on profitability, with a higher operating margin.
HMN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $439.2M | +0.2% |
| Q2 2026 | $443.5M | +7.7% |
| Q1 2026 | $429.3M | +3.1% |
| Q4 2025 | $434.8M | +6.3% |
| Q3 2025 | $438.5M | +6.4% |
| Q2 2025 | $411.7M | +6.1% |
| Q1 2025 | $416.4M | +7.9% |
| Q4 2024 | $409M | +1.5% |
HMN's revenue has grown year over year for 17 quarters in a row: $439M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 17% | +0.2 points |
| Q2 2026 | 11% | +2.2 points |
| Q1 2026 | 12% | +0.3 points |
| Q4 2025 | 11% | -1.3 points |
| Q3 2025 | 16% | +5.9 points |
| Q2 2025 | 8.9% | +7.7 points |
| Q1 2025 | 11% | +2.9 points |
| Q4 2024 | 12% | +0.1 points |
HMN's operating margin was 17% last quarter, about level with the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC's free cash flow was $41.4B over the past year, down 33% from the year before. Free cash flow isn't a meaningful measure for financial services companies like BAC.
HMN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $112M | -26% |
| Q2 2026 | $223.7M | +70% |
| Q1 2026 | $61.3M | -56% |
| Q4 2025 | $129.9M | -33% |
| Q3 2025 | $151.2M | +5.1% |
| Q2 2025 | $131.3M | +227% |
| Q1 2025 | $140.8M | +89% |
| Q4 2024 | $193.5M | +88% |
HMN has the edge over BAC on cash flow, with more consistent year-over-year improvement.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has the edge over HMN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
HMN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.5% | +200K shares |
| 1 year | -0.5% | -200K shares |
| 3 years | 0% | -- |
| 5 years | -1.9% | -800K shares |
| Available history | -1.5% | -619K shares |
HMN has 41M diluted shares, about the same as a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1M |
| Q2 2026 | $100,000 |
| Q1 2026 | $18.3M |
| Q4 2025 | $6.9M |
| Q3 2025 | $6.8M |
| Q2 2025 | $6.9M |
| Q1 2025 | $200,000 |
| Q4 2024 | — |
HMN spent $26M buying back its own shares over the past year, up 89% from the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
HMN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.8x | Healthy |
| Q2 2026 | 2.3x | Moderate |
| Q1 2026 | 2.5x | Moderate |
| Q4 2025 | 2.5x | Moderate |
| Q3 2025 | 3.4x | Elevated |
| Q2 2025 | 2.5x | Moderate |
| Q1 2025 | 3.1x | Elevated |
| Q4 2024 | 3.3x | Elevated |
HMN has the edge over BAC on leverage, with a lower net debt burden relative to earnings.
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
HMN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 63.5 | Neutral |
| Stochastic | 63.6 | Neutral |
HMN's weekly RSI is 63 (neutral) and its Stochastic is 64 (neutral).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC has the edge over HMN on valuation relative to its sector.
HMN PE vs Financial Services Sector
| Metric | HMN | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 5.5% below |
| PE % | 42 | 63 | 21 pts below |
HMN is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
HMN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $47.7 | 11% above |
| 20 week MA | $50.0 | 5.6% above |
| 50 week MA | $46.9 | 12% above |
| 100 week MA | $44.7 | 18% above |
| 200 week MA | $39.3 | 34% above |
HMN has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
HMN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $43.7 | $41.7 | -4.6% |
| 2021 | $41.7 | $38.6 | -7.5% |
| 2022 | $38.6 | $37.9 | -1.8% |
| 2023 | $37.9 | $32.7 | -14% |
| 2024 | $32.7 | $39.3 | +20% |
| 2025 | $39.3 | $46.5 | +18% |
| 2026 YTD | $46.5 | $52.8 | +14% |
HMN has the edge over BAC on returns for 2026, with the stronger performance.